Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Open-label, Active Comparator-controlled, Extension Trial To Evaluate The Long-term Safety And Efficacy Of Cp-690,550 In Renal Allograft Recipients
Conditions
Interventions
Cyclosporine
CP-690,550
+1 more
Locations
65
United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Cedars-Sinai MedicalCenter
Los Angeles, California, United States
Ronald Reagan UCLA Medical Center
Los Angeles, California, United States
UCLA Medical Center
Los Angeles, California, United States
Stanford School of Medicine
Palo Alto, California, United States
Stanford University Medical Center
Palo Alto, California, United States
Start Date
August 1, 2008
Primary Completion Date
March 1, 2015
Completion Date
June 1, 2015
Last Updated
February 23, 2018
NCT05753930
NCT04128189
NCT06568549
NCT04870437
NCT07415421
NCT06958796
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions